Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Regeneron Pharmaceuticals (REGN.VI) Q3 2025 Earnings
REGN.VI
1
Aug
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
7.22
8.69
10.16
11.64
Details
Expected EPS
7.2750287874
Actual EPS
11.122781
Surprise EPS
3.85
Surprise Percent
+52.89%
Description
Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 11.122781 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login